November 2007- Volume 3, Issue 11
November 2007
In this Issue
Research & Development
Back to nature
Back to nature
Cystic Fibrosis Foundation enters deal with AMRI
Dueling with diabetes
Dueling with diabetes
Vitae and Boehringer Ingelheim pair up to advance an inhibitor with promise to treat diabetes and other related disease states
From service to innovation
From service to innovation
The next stage in Indian pharma evolution is on the way
From service to innovation
From service to innovation
The next stage in Indian pharma evolution
Neglected no longer?
Neglected no longer?
Tackling infectious disease where it lives
Global News
Genzyme seals Bioenvision deal
Genzyme seals Bioenvision deal
Company stands firm on offer of $345 million for New York-based biotech
Blockbuster oncology deal
Blockbuster oncology deal
Synta could reap more than $1 billion from deal with GSK on STA-4783
Informatics
Customized CRO services
Customized CRO services
Nextrials, Protrials team up to provide integrated clinical services
Floating to the top?
Floating to the top?
CambridgeSoft seeks to float its stock on alternative market operated by the London Stock Exchange
Fast track for Compendia
Fast track for Compendia
Company secures $2.4 million Phase I and II SBIR grant
Malaria “Survey”
Malaria “Survey”
U.S. Army research from 1946 plus 21st century informatics aid in research of resistant strains of malaria
Automation & Instrumentation
Getting a foot in the door
Getting a foot in the door
Agilent-BioTrove co-marketing deal could open opportunities for closer ties
Imaging is everything
Imaging is everything
Alpha Innotech to create new device for OEM agreement with R&C Biogenius
Genomics & Proteomics
Adding to the family tree
Adding to the family tree
BioServe, DNAPrint Genomics add ancestry data to biological samples
Continued transformation
Continued transformation
Gene Logic sells genomics assets to Ocimum Biosolutions for $10 million
Getting personal in Arizona
Getting personal in Arizona
Piper Trust, Flinn Foundation fund personalized medicine initiative
